BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28089633)

  • 21. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
    Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
    Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG island hypermethylation in progression of esophageal and gastric cancer.
    Sato F; Meltzer SJ
    Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
    Kandioler D; Schoppmann SF; Zwrtek R; Kappel S; Wolf B; Mittlböck M; Kührer I; Hejna M; Pluschnig U; Ba-Ssalamah A; Wrba F; Zacherl J
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2280-6. PubMed ID: 25135238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese Classification of Esophageal Cancer, 12th Edition: Part II.
    Doki Y; Tanaka K; Kawachi H; Shirakawa Y; Kitagawa Y; Toh Y; Yasuda T; Watanabe M; Kamei T; Oyama T; Seto Y; Murakami K; Arai T; Muto M; Mine S
    Esophagus; 2024 Jul; 21(3):216-269. PubMed ID: 38512393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histology, anatomy, or geography? Exome sequencing begins to delineate somatic mutational differences in esophageal cancer.
    Collisson EA; Cho RJ
    Cancer Discov; 2012 Oct; 2(10):870-1. PubMed ID: 23071029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
    Hayakawa Y; Sethi N; Sepulveda AR; Bass AJ; Wang TC
    Nat Rev Cancer; 2016 Apr; 16(5):305-18. PubMed ID: 27112208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
    Greenawalt DM; Duong C; Smyth GK; Ciavarella ML; Thompson NJ; Tiang T; Murray WK; Thomas RJ; Phillips WA
    Int J Cancer; 2007 May; 120(9):1914-21. PubMed ID: 17236199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oesophageal and gastric pathology: early neoplastic lesions. case 1: squamous intraepithelial neoplasia of the oesophagus].
    Chatelain D; Fléjou JF
    Ann Pathol; 2011 Oct; 31(5):356-62. PubMed ID: 21982242
    [No Abstract]   [Full Text] [Related]  

  • 32. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
    Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
    Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.
    Montesano R; Hollstein M; Hainaut P
    Int J Cancer; 1996 Jun; 69(3):225-35. PubMed ID: 8682592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
    Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
    Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
    Shen LY; Wang H; Dong B; Yan WP; Lin Y; Shi Q; Chen KN
    Oncotarget; 2016 Jan; 7(4):4531-41. PubMed ID: 26673820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
    Smith E; Palethorpe HM; Hayden AL; Young JP; Underwood TJ; Drew PA
    Sci Rep; 2017 Jun; 7(1):3368. PubMed ID: 28611465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.
    Kunzmann AT; Cañadas Garre M; Thrift AP; McMenamin ÚC; Johnston BT; Cardwell CR; Anderson LA; Spence AD; Lagergren J; Xie SH; Smyth LJ; McKnight AJ; Coleman HG
    Gastroenterology; 2019 Jan; 156(1):43-45. PubMed ID: 30243622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.
    Kanamarlapudi V; Tamaddon-Jahromi S; Murphy K
    PLoS One; 2022; 17(2):e0263845. PubMed ID: 35143561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.